HERON THERAPEUTICS, INC. /DE/ Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $5.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-26
- HERON THERAPEUTICS, INC. /DE/ effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $5.70M, a 28.45% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $7.97M, a 58.11% decline from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $19.02M, a 224.77% increase from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $5.86M, a 27.77% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | $5.70M 10-K · filed 2026-02-26 |
| 2024-12-31 | $7.97M 10-K · filed 2026-02-26 |
| 2023-12-31 | $19.02M 10-K · filed 2026-02-26 |
| 2022-12-31 | $5.86M 10-K · filed 2025-02-27 |
| 2021-12-31 | $4.58M 10-K · filed 2023-03-29 |
| 2020-12-31 | $4.67M 10-K · filed 2022-02-28 |
| 2019-12-31 | $2.91M 10-K · filed 2022-02-28 |
| 2018-12-31 | -$2.06M 10-K · filed 2021-02-24 |
| 2017-12-31 | $3.15M 10-K · filed 2020-03-02 |
| 2016-12-31 | $2.69M 10-K · filed 2019-02-22 |
| 2015-12-31 | $894.00K 10-K · filed 2018-02-27 |
| 2014-12-31 | $551.00K 10-K · filed 2017-02-23 |
| 2013-12-31 | $513.00K 10-K · filed 2016-02-19 |
| 2012-12-31 | $176.00K 10-K · filed 2015-03-13 |
| 2011-12-31 | $148.00K 10-K · filed 2014-03-07 |
| 2010-12-31 | $173.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |